INS and Hyperglycemia: Kuo et al., “Caffeamide 36-13 Regulates the Antidiabetic and Hypolipidemic Signs of High-Fat-Fed Mice on Glucose Transporter 4, AMPK Phosphorylation, and Regulated Hepatic Glucose Production,” reports that caffeamide 36-13 (TS), a caffeic acid amide, improved hyperglycemia and hyperlipidemia in high fat diet-fed mice as evidenced by the level of blood glucose, triglyceride, insulin, leptin, and free fatty acid (FFA).